1. Pre-Operative Calcitonin and CEA Values May Predict the Extent of Metastases to the Lateral Neck Lymph Nodes in Patients with Medullary Thyroid Cancer.
- Author
-
Prinzi, Antonio, Frasca, Francesco, Russo, Marco, Pellegriti, Gabriella, Piticchio, Tommaso, Tumino, Dario, Belfiore, Antonino, and Malandrino, Pasqualino
- Subjects
LYMPH node surgery ,PREOPERATIVE period ,THYROID gland tumors ,T-test (Statistics) ,RECEIVER operating characteristic curves ,CANCER relapse ,KRUSKAL-Wallis Test ,TUMOR markers ,CALCITONIN ,DECISION making in clinical medicine ,CANCER patients ,RETROSPECTIVE studies ,CHEMILUMINESCENCE assay ,DESCRIPTIVE statistics ,CHI-squared test ,METASTASIS ,CANCER cells ,NEUROENDOCRINE tumors ,TUMOR antigens ,TUMOR classification ,IMMUNOASSAY ,DATA analysis software ,NECK surgery ,THYROIDECTOMY ,SENSITIVITY & specificity (Statistics) ,REGRESSION analysis - Abstract
Simple Summary: Total thyroidectomy and dissection of cervical lymph node compartments, depending on serum calcitonin levels and ultrasound findings, is standard treatment for patients with medullary thyroid cancer. The aim of this study was to evaluate whether pre-operative calcitonin and CEA levels can be useful as biomarkers of the extent of lymph node metastases at diagnosis. Results indicate that pre-operative serum calcitonin and CEA levels can predict presence, number, and site of lymph node metastases and, more specifically, values of 90 pg/mL for calcitonin and 17 ng/mL for CEA accurately indicate the N1b status. Since surgery is the only curative treatment for medullary thyroid cancer and there is not a strong indication regarding the extent of lymphadenectomy, these findings may help in the choice of the extent of neck dissection. Background: In medullary thyroid cancer (MTC), lymph node metastases are often present at diagnosis and the extent of surgery is usually based upon pre-operative calcitonin and CEA levels as well as ultrasound findings. The aim of this study was to evaluate the role of pre-operative calcitonin and CEA levels as predictive markers of the burden of lymph node metastases at diagnosis. Methods: we conducted a retrospective study analyzing 87 MTC patients. Results: The median levels of calcitonin and CEA were 88.4 pg/mL and 7.0 ng/mL, respectively, in patients with no lymph nodes metastases; 108.0 pg/mL and 9.6 ng/mL, respectively, in patients with metastases to 1–5 lymph nodes; 520.5 pg/mL and 43.2 ng/mL, respectively, in patients with metastases to >5 lymph nodes. There were no significant differences in pre-operative calcitonin and CEA values between N0 and N1a patients, whereas they were significantly higher in N1b patients. Pre-operative cut-off levels distinguishing N0/N1a from N1b patients were 90 pg/mL for calcitonin (sensitivity 100%, specificity 59.3%, AUC = 0.82) and 17 ng/mL for CEA (sensitivity 100%, specificity 75%, AUC = 0.89). Conclusions: in patients with MTC, pre-operative serum calcitonin and CEA levels may drive the decision-making process to better define the extent of surgery. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF